| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $692.6M | -11.5% |
| Cost of Revenue | $536.2M | -11.6% |
| R&D Expense | $5.2M | +15.6% |
| SG&A Expense | $95.0M | +0.9% |
| Operating Income | -$1.7M | -107.3% |
| Pre-tax Income | -$7.9M | -149.6% |
| Income Tax | $3.4M | +16.1% |
| Net Income | -$11.3M | -187.3% |
| EPS (Basic) | -$0.18 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.4M | +38.7% |
| Accounts Receivable | $194.3M | -4.4% |
| Inventory | $214.8M | +6.3% |
| Current Assets | $498.2M | +2.1% |
| Total Assets | $1.01B | -4.0% |
| Current Liabilities | $157.7M | +0.3% |
| Long-term Debt | $124.7M | -8.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.9M | -18.9% |
| Investing Cash Flow | $2.7M | +110.6% |
| Financing Cash Flow | -$29.5M | -10.4% |
| -190.0% |
| EPS (Diluted) | -$0.18 | -190.0% |
| Total Liabilities |
| $324.5M |
| -3.7% |
| Stockholders' Equity | $680.7M | -4.1% |